{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:58:55Z","timestamp":1780995535921,"version":"3.54.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.clinbiochem.2012.09.009","type":"journal-article","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T12:32:38Z","timestamp":1347971558000},"page":"37-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Purine metabolites in fibromyalgia syndrome"],"prefix":"10.1016","volume":"46","author":[{"given":"A.","family":"Fais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cacace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Corda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Era","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Peri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Utzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinbiochem.2012.09.009_bb0005","first-page":"226","article-title":"Quality of life and associated clinical distress in fibromyalgia","volume":"58","author":"Cacace","year":"2006","journal-title":"Reumatismo"},{"key":"10.1016\/j.clinbiochem.2012.09.009_bb0085","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.semarthrit.2007.09.003","article-title":"Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness","volume":"37","author":"Yunus","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clinbiochem.2012.09.009_bb0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinbiochem.2012.09.009_bb0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/pr.58.1.5","article-title":"Pathophysiology and therapeutic potential of purinergic signaling","volume":"58","author":"Burnstock","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.clinbiochem.2012.09.009_bb0025","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1096\/fj.02-1136fje","article-title":"Soluble purine-converting enzymes circulate in human blood and regulate extracellular ATP level via counteracting pyrophosphatase and phosphotransfer reactions","volume":"17","author":"Yegutkin","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.clinbiochem.2012.09.009_bb0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tips.2004.01.006","article-title":"Immunomodulatory and neuroprotective effects of inosine","volume":"25","author":"Hask\u00f3","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.clinbiochem.2012.09.009_bb0035","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/BF01785710","article-title":"Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose","volume":"64","author":"Z\u00f6llner","year":"1986","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.clinbiochem.2012.09.009_bb0040","first-page":"S154","article-title":"The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses","volume":"23","author":"Bennett","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clinbiochem.2012.09.009_bb0045","first-page":"6","article-title":"Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment","volume":"32","author":"Mease","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinbiochem.2012.09.009_bb0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0301-0082(03)00050-9","article-title":"Adenosine in the spinal cord and periphery: release and regulation of pain","volume":"69","author":"Sawynok","year":"2003","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.clinbiochem.2012.09.009_bb0095","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/annrheumdis-2011-201174","article-title":"High cell surface CD26-associated activities and low plasma adenosine concentration in fibromyalgia","volume":"71","author":"Guieu","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinbiochem.2012.09.009_bb0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/096876800110033783","article-title":"Complex regulation of nucleoside transporter expression in epithelial and immune system cells","volume":"18","author":"Pastor-Anglada","year":"2001","journal-title":"Mol Membr Biol"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.09.009_bb0100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00404-012-2279-5","article-title":"Adenosine deaminase activity in patients with ovarian neoplasms","volume":"286","author":"Urunsak","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.clinbiochem.2012.09.009_bb0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0301-0082(99)00017-9","article-title":"Trophic effects of purines in neurons and glial cells","volume":"59","author":"Rathbone","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.clinbiochem.2012.09.009_bb0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-5793(96)00023-3","article-title":"Adenosine deaminase affects ligand-induced signaling by interacting with cell surface adenosine receptors","volume":"380","author":"Ciruela","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clinbiochem.2012.09.009_bb0080","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1152\/ajpendo.00173.2005","article-title":"Inosine released after hypoxia activates hepatic glucose liberation through A3 adenosine receptors","volume":"290","author":"Guinzberg","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012005395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012005395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:40:45Z","timestamp":1757864445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912012005395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":16,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0009912012005395"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.09.009","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purine metabolites in fibromyalgia syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}